Method of reducing pulmonary exacerbations in respiratory disease patients
US11890282B2 · kind B2 · utility
0Cited by
7References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2021 |
| Grant date | Feb 6, 2024 |
| Priority date | — |
| Expiry date | Jun 23, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are methods of reducing pulmonary exacerbations and methods of treating cystic fibrosis, including methods of reducing pulmonary inflammation, comprising administration of an LTA4h inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.